Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBC-103 in MPS IIIB
NCT02324049Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jan 2015
- Primary completion
- Oct 2017
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of lesinidase alfa in Mucopolysaccharidosis Type IIIB, sponsored by Alexion Pharmaceuticals. Started Jan 2015; status: completed.
02
Drugs
lesinidase alfa
03
Conditions
Mucopolysaccharidosis Type IIIB
Beyond the preview
Go deeper on NCT02324049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02324049.